4//SEC Filing
ValueAct Holdings GP, LLC 4
Accession 0001418812-21-000021
CIK 0000885590other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 7:27 PM ET
Size
20.9 KB
Accession
0001418812-21-000021
Insider Transaction Report
Form 4
ValueAct Holdings GP, LLC
DirectorOther
Transactions
- Award
Common Shares, no par value
2021-04-30+7,645→ 18,682 total
Holdings
- 17,941,603(indirect: See footnotes.)
Common Shares, no par value
ValueAct Capital Management, L.P.
DirectorOther
Transactions
- Award
Common Shares, no par value
2021-04-30+7,645→ 18,682 total
Holdings
- 17,941,603(indirect: See footnotes.)
Common Shares, no par value
ValueAct Holdings II, L.P.
DirectorOther
Transactions
- Award
Common Shares, no par value
2021-04-30+7,645→ 18,682 total
Holdings
- 17,941,603(indirect: See footnotes.)
Common Shares, no par value
ValueAct Capital Master Fund, L.P.
DirectorOther
Transactions
- Award
Common Shares, no par value
2021-04-30+7,645→ 18,682 total
Holdings
- 17,941,603(indirect: See footnotes.)
Common Shares, no par value
VA Partners I, LLC
DirectorOther
Transactions
- Award
Common Shares, no par value
2021-04-30+7,645→ 18,682 total
Holdings
- 17,941,603(indirect: See footnotes.)
Common Shares, no par value
ValueAct Capital Management, LLC
DirectorOther
Transactions
- Award
Common Shares, no par value
2021-04-30+7,645→ 18,682 total
Holdings
- 17,941,603(indirect: See footnotes.)
Common Shares, no par value
Hale David Robert
DirectorOther
Transactions
- Award
Common Shares, no par value
2021-04-30+7,645→ 18,682 total
Holdings
- 17,941,603(indirect: See footnotes.)
Common Shares, no par value
ValueAct Holdings, L.P.
DirectorOther
Transactions
- Award
Common Shares, no par value
2021-04-30+7,645→ 18,682 total
Holdings
- 17,941,603(indirect: See footnotes.)
Common Shares, no par value
Footnotes (4)
- [F1]Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.
- [F2]All board compensation accrues to the benefit of the investors in ValueAct Capital Master Fund, L.P., and not to any individual. Under an agreement with ValueAct Capital, D. Robert Hale is deemed to hold the restricted share units for the benefit of the limited partners of ValueAct Capital Master Fund, L.P. and indirectly for the entities listed in (i) to (vi) footnote 4 herein.
- [F3]Each reporting person listed herein disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F4]The securities reported herein are held by ValueAct Capital Master Fund, L.P. and may be deemed to be indirectly beneficially owned by (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the majority owner of the membership interests of VA Partners I, LLC, (v) ValueAct Holdings II, L.P. as the sole owner of the membership interests of ValueAct Capital Management, LLC and as the majority owner of the limited partnership interests of ValueAct Capital Management, L.P., and (vi) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. and ValueAct Holdings II, L.P.
Documents
Issuer
Bausch Health Companies Inc.
CIK 0000885590
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001418813
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 7:27 PM ET
- Size
- 20.9 KB